Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 patients.

World-class Kabuki theatre took the stage at the U.S. International Trade Commission (USITC) last week. Big Pharma interests raged en masse: Death and misery would befall us all if the U.S. government ...

After raking in billions with its Pfizer-partnered vaccine, BioNTech is turning to new ventures as its revenues plummet. BioNTech reported first-quarter revenues of 1.27 billion euros (1.4 billion), a ...

Although trust in pharma spiked during the pandemic, it seems companies' reputations are back to pre-COVID-19 levels—and there’s bad news for the biggest COVID vaccine makers. That’s according to a ...

Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral reboundsActivity shown in Paxlovid®-ineligible ...

I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...

Despite Trump pressure, Big Pharma is raising hundreds of drug prices - Costs of at least 350 branded medications, including ...

Fosun Pharma’s revenue grew slightly in the first quarter on its diverse product portfolio, while its net profit soared by 116%. CanSino’s revenue plunged 80% in the same three-month period, and it ...

The financial performance of major pharmaceutical companies highlights the divergent trajectories of success of GLP-1 manufacturers and the weakness caused by diminishing Covid-19 sales. Eli Lilly and ...

Fosun Pharma’s net profit fell more than 20% last year due to a 30% drop in sales of its Comirnaty Covid vaccine and investment losses. The company’s innovative drugs generated more than 10 billion ...

LONDON, July 19 (Reuters) - An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights for COVID-19 ...